CTOR — Citius Oncology, Inc.

CTORCitius Oncology, Inc.

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic

0.8450USD+0.60%Mkt Cap: 79.87M USDP/E: —Last update: 2026-05-26

Citius Oncology, Inc. focuses on the development and commercialization of innovative targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients wi…

Industry Peers

Drug Manufacturers - Specialty & Generic

SOBI

Swedish Orphan Biovitrum AB (publ)

152.45BSEKP/E 166.3

ECILC

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.

United Therapeutics Corporation

Neurocrine Biosciences, Inc.

Indicators:|

Key Statistics

Company

Market Cap79.87M USD

Enterprise Value78.25M USD

Revenue (TTM)5.61M USD

Gross Profit4.49M USD

Net Income (TTM)-24.76M USD

Revenue/Share0.0670 USD

Last Price0.8450 USD

Fiscal Year EndSep 2025

MR QuarterMar 2026

Employees—

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue13.94

P/S13.74

P/B2.19

EPS (TTM)-0.48

EPS (Forward)—

52W Range

0.49106% of range6.190

52W High6.190 USD

52W Low0.4910 USD

Profitability

Gross Margin80.07%

Oper. Margin-1716.17%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-55.19%

ROA-24.53%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-5.49M USD

CapEx (TTM)5.75M USD

FCF Margin-420.87%

FCF Yield-29.57%

Net Debt1.17M USD

Net Debt/EBITDA—

Balance Sheet

Debt/Equity0.08

Current Ratio0.50

Quick Ratio0.06

Book Value/Sh0.3790 USD

Cash/Share0.0280 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating2.0 (Buy)

Target (Mean)4.000 USD

Target Range4.000 USD – 4.000 USD

# Analysts1

Ownership

Shares Out.92.98M

Float14.88M

Insiders79.64%

Institutions15.32%

Short Interest

Short Ratio4.4d

Short % Float2.95%

Short % Out.0.74%

Shares Short655.07K

Short (prev mo.)1.06M

Technical

SMA 500.7921 (+6.7%)

SMA 2001.278 (-33.9%)

Beta—

S&P 52W Chg28.31%

Avg Vol (30d)107.15K

Avg Vol (10d)95.38K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—